Apollo Medical Holdings, Inc.(AMEH) Stock Research - Grey Stern Research

Apollo Medical Holdings, Inc. (AMEH) Stock Analysis

$40.82 (-2.11%)

AMEH Financial Performance


Use the table below to view Apollo Medical Holdings, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2023

Metric Value Ranking among Peers
Price $40.82 -
52 Week Low $28.87 -
52 Week High $45.71 -
Market Cap $1.8 Billion 11/14
Gross Margin 21% 8/14
Profit Margin 6% 5/14
EBITDA margin 12% 4/14
Q3 - 2023 Revenue $348.2 Million 9/14
Q3 - 2023 Earnings $22.1 Million 6/14
Q3 - 2023 Free Cash Flow $11.3 Million 8/14
Trailing 4 Quarters Revenue $1.3 Billion 10/14
Trailing 4 Quarters Earnings $50.3 Million 9/14
Quarterly Earnings Growth -15% 8/14
Annual Earnings Growth -16% 12/14
Quarterly Revenue Growth 10% 9/14
Annual Revenue Growth 18% 2/14
Cash On Hand $103.2 Million 7/14
Short Term Debt $3.2 Million 12/14
Long Term Debt $0 13/14

Apollo Medical Holdings, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Apollo Medical Holdings, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 36.37 3/14
PS 1.38 5/14
PB 2.17 6/14
PC 17.73 7/14
Liabilities to Equity 0.00 14/14
ROA 0.06 3/14
ROE -1.00 14/14
Current Ratio 30.71 1/14
Quick Ratio 3.65 1/14
Long Term Debt to Equity -1.00 14/14
Debt to Equity -1.00 14/14
Burn Rate -4.86 11/14
Cash to Cap 0.06 6/14
CCR 0.51 5/14
EV to EBITDA 39.93 8/14
EV to Revenue 1.31 8/14

Company Details

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

CEO: Dr. Kenneth Sim

Website: https://www.apollomed.net

Address: 1668 S Garfield Ave Fl 2nd Alhambra, CALIFORNIA

Exchange: NASDAQ Capital Market

Industry: Medical Care Facilities

Apollo Medical Holdings, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Apollo Medical Holdings, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Healthcare Services Group, Inc. HCSG $694.2 Million
Universal Health Services, Inc. UHS $11.4 Billion
Acadia Healthcare Company, Inc. ACHC $2.2 Billion
Surgery Partners, Inc. SGRY $2.7 Billion
Select Medical Holdings Corporation SEM $2.1 Billion
Encompass Health Corporation EHC $10.4 Billion
Amedisys, Inc. AMED $3.0 Billion
Addus HomeCare Corporation ADUS $1.8 Billion
The Ensign Group, Inc. ENSG $7.4 Billion
Option Care Health, Inc. OPCH $5.3 Billion
The Pennant Group, Inc. PNTG $907.3 Million
InnovAge Holding Corp. INNV $371.9 Million
LifeStance Health Group, Inc. LFST $2.6 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
AMEH Income Statements
Quarter Year Revenue Earnings
Q3 2023 $ 348.2 Million $22.1 Million
Q2 2023 $ 348.2 Million $13.2 Million
Q1 2023 $ 335.6 Million $14.6 Million
Q4 2022 $ 292.8 Million $471,000
Q3 2022 $ 317.0 Million $26.0 Million
Q2 2022 $ 269.7 Million $11.4 Million
Q1 2022 $ 263.3 Million $14.3 Million
Q4 2021 $ 193.6 Million $13.8 Million

View All

AMEH Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2023 $103.2 Million $871.8 Million $3.2 Million $0
Q2 2023 $293.9 Million $1.0 Billion $230.3 Million $566.0 Million
Q1 2023 $274.6 Million $992.6 Million $228.7 Million $560.0 Million
Q4 2022 $288.0 Million $963.9 Million $229.4 Million $552.8 Million
Q3 2022 $184.0 Million $943.4 Million $223.1 Million $553.3 Million
Q2 2022 $234.2 Million $951.1 Million $223.2 Million $525.8 Million
Q1 2022 $237.9 Million $912.3 Million $201.5 Million $531.7 Million
Q4 2021 $233.1 Million $852.4 Million $201.0 Million $460.5 Million

View All

AMEH Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2023 $11.3 Million -$4.1 Million -$20.0 Million
Q2 2023 $23.3 Million -$2.5 Million $19.7 Million
Q1 2023 -$7.1 Million -$14.9 Million -$13.4 Million
Q4 2022 $84.1 Million -$886,000 $104.0 Million
Q3 2022 -$39.1 Million -$3.2 Million $0
Q2 2022 $7.7 Million -$1.4 Million $0
Q1 2022 $6.5 Million -$17.5 Million $4.8 Million
Q4 2021 $4.2 Million $0 $0

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions